Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgecine for chronic low back pain after surgery
NCT02168010Phase 3Completed
- Sponsor
- Vanworld Pharmaceutical (Rugao) Co., Ltd.
- Start
- Oct 2013
- Primary completion
- Jul 2014
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of Analgecine in chronic low back pain (CLBP), sponsored by Vanworld Pharmaceutical (Rugao) Co., Ltd.. Started Oct 2013; status: completed.
02
Drugs
Analgecine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02168010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168010.